Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PROCEPT BioRobotics (PRCT) Equity Average (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Equity Average for 6 consecutive years, with $373.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Equity Average rose 15.96% to $373.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $373.1 million, a 15.96% increase, with the full-year FY2025 number at $384.0 million, up 12.46% from a year prior.
  • Equity Average was $373.1 million for Q4 2025 at PROCEPT BioRobotics, down from $383.0 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $395.7 million in Q1 2025 to a low of -$200.1 million in Q2 2021.
  • A 5-year average of $218.8 million and a median of $252.2 million in 2024 define the central range for Equity Average.
  • Peak YoY movement for Equity Average: soared 497.29% in 2022, then plummeted 33.12% in 2023.
  • PROCEPT BioRobotics' Equity Average stood at $275.2 million in 2021, then fell by 24.09% to $208.9 million in 2022, then soared by 38.84% to $290.1 million in 2023, then grew by 10.92% to $321.7 million in 2024, then increased by 15.96% to $373.1 million in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Equity Average are $373.1 million (Q4 2025), $383.0 million (Q3 2025), and $387.5 million (Q2 2025).